|
⚲
|
| Keyboard |
| Bain Capital Life Sciences Fund LP
✚
|
|
|---|---|
| CIK # | 0001687968 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001687968] | |
| 3 | [0001687968] | |
| 4 | [0001687968] | |
| D | [0001687968] | |
| SC 13D | [0001687968] | |
| SC 13G | [0001687968] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Annexon Inc ANNX
Common Stock
|
2023-05-25 | Buy | 300,000 | $2.13 | 639,000 |
|
Rapid Micro Biosystems Inc RPID
Series B1 Preferred Stock · derivative
|
2021-07-19 | Conversion | 35,000,001 | ||
|
Rapid Micro Biosystems Inc RPID
Series C1 Preferred Stock · derivative
|
2021-07-19 | Conversion | 6,672,819 | ||
|
Rapid Micro Biosystems Inc RPID
Class A Common Stock
|
2021-07-19 | Conversion | 1,334,562 | ||
|
Rapid Micro Biosystems Inc RPID
Class A Common Stock
|
2021-07-19 | Conversion | 6,999,998 | ||
|
Rapid Micro Biosystems Inc RPID
Class A Common Stock
|
2021-07-19 | Buy | 100,000 | $20.00 | 2,000,000 |
|
Aptinyx Inc APTX
Common Stock
|
2020-10-26 | Buy | 3,333,333 | $3.00 | 9,999,999 |
|
Annexon Inc ANNX
Common Stock
|
2020-07-28 | Conversion | 319,243 | ||
|
Annexon Inc ANNX
Series C Preferred Stock · derivative
|
2020-07-28 | Conversion | 22,222,221 | ||
|
Annexon Inc ANNX
Series D Preferred Stock · derivative
|
2020-07-28 | Conversion | 2,812,543 | ||
|
Annexon Inc ANNX
Common Stock
|
2020-07-28 | Buy | 400,000 | $17.00 | 6,800,000 |
|
Annexon Inc ANNX
Common Stock
|
2020-07-28 | Conversion | 2,522,385 | ||
|
Arcutis Biotherapeutics Inc ARQT
Common Stock
|
2020-02-04 | Buy | 294,117 | $17.00 | 4,999,989 |
|
Arcutis Biotherapeutics Inc ARQT
Common Stock
|
2020-02-04 | Conversion | 859,573 | ||
|
Arcutis Biotherapeutics Inc ARQT
Common Stock
|
2020-02-04 | Conversion | 2,825,602 | ||
|
Arcutis Biotherapeutics Inc ARQT
Series C Preferred Stock · derivative
|
2020-02-04 | Conversion | 859,573 | $0.00 | |
|
Arcutis Biotherapeutics Inc ARQT
Series B Preferred Stock · derivative
|
2020-02-04 | Conversion | 2,825,602 | $0.00 | |
|
Dicerna Pharmaceuticals Inc DRNA
Common Stock
|
2019-11-19 | Sell | 1,750,000 | $22.03 | 38,552,500 |
|
Dicerna Pharmaceuticals Inc DRNA
Common Stock
|
2019-05-29 | Sell | 1,600,000 | $12.50 | 20,000,000 |
|
Replimune Group Inc REPL
Series B Convertible Preferred Stock · derivative
|
2018-07-24 | Conversion | 235,146 | ||
| showing 20 of 31 most recent transactions | |||||